Merck & Co., Inc. (MRK) Expected to Announce Quarterly Earnings on Tuesday

Merck & Co., Inc. (NYSE:MRK) is anticipated to announce its earnings results before the market opens on Tuesday, February 4th. Analysts expect the company to announce earnings of $1.85 per share and revenue of $15,553,132.98 billion for the quarter. Merck & Co., Inc. has set its FY 2024 guidance at 7.720-7.770 EPS and its FY24 guidance at $7.72-7.77 EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Merck & Co., Inc. (NYSE:MRK) last released its quarterly earnings results on Thursday, October 31st. The company reported $1.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.50 by $0.07. Merck & Co., Inc. had a net margin of 19.23% and a return on equity of 36.42%. The firm had revenue of $16.66 billion for the quarter, compared to the consensus estimate of $16.47 billion. During the same quarter in the previous year, the firm posted $2.13 EPS. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. On average, analysts expect Merck & Co., Inc. to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Merck & Co., Inc. Stock Up 2.5 %

Shares of NYSE MRK opened at $97.99 on Tuesday. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.15 and a current ratio of 1.36. Merck & Co., Inc. has a 1 year low of $94.48 and a 1 year high of $134.63. The stock’s 50-day simple moving average is $99.80 and its 200-day simple moving average is $108.56. The firm has a market cap of $247.87 billion, a price-to-earnings ratio of 20.54, a PEG ratio of 1.13 and a beta of 0.39.

Merck & Co., Inc. Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 8th. Stockholders of record on Monday, December 16th were paid a dividend of $0.81 per share. This is a boost from Merck & Co., Inc.’s previous quarterly dividend of $0.77. This represents a $3.24 annualized dividend and a dividend yield of 3.31%. The ex-dividend date of this dividend was Monday, December 16th. Merck & Co., Inc.’s dividend payout ratio is 67.92%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Bank of America reissued a “buy” rating and set a $121.00 price objective on shares of Merck & Co., Inc. in a report on Tuesday, December 10th. Daiwa Capital Markets downgraded Merck & Co., Inc. from a “buy” rating to a “neutral” rating in a report on Monday, November 11th. Daiwa America lowered Merck & Co., Inc. from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 11th. Wells Fargo & Company decreased their price objective on shares of Merck & Co., Inc. from $125.00 to $110.00 and set an “equal weight” rating for the company in a report on Friday, November 1st. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $155.00 price target on shares of Merck & Co., Inc. in a research report on Thursday, October 3rd. One analyst has rated the stock with a sell rating, eight have given a hold rating, nine have given a buy rating and four have assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $123.00.

About Merck & Co., Inc.

Merck & Co, Inc is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.